• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1234350-18
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/21/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.Based on the information reviewed, a conclusive cause for the reported difficulty to deploy could not be determined.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other incidents from this lot.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the patient presented with severe chest pain.The procedure on (b)(6) 2017 was to treat a lesion located in the proximal to mid left anterior descending (lad) artery with a chronic total occlusion.Vessel sizing was performed with intra-vascular ultrasound which determined that the vessel size was 3.5mm.Pre-dilatation of the mid lad was performed with a 3.0x12mm nc trek with residual stenosis reduced to less than 10%.A 3.0x18mm absorb gt1 was implanted smoothly.A second absorb gt1 (3.5x18mm) was advanced for overlap with the first 3.0x18mm absorb gt1; however, during expansion of the 3.5x18mm absorb gt1, the scaffold suddenly retreated from the original location.The scaffold was deployed partially in the target lesion; however, the scaffold edge was found to be protruding 3mm into the left circumflex.Timi blood flow was 3 and the patient was without any discomfort.The patient was discharged on dual anti-platelet therapy (dapt) on (b)(6) 2017.On the third day after discharge, (b)(6) 2017, the patient went back to the hospital with a severe headache.A brain computer tomography was performed and an intracranial hemorrhage was identified.The consulting neurological surgeon stated the intracranial hemorrhage was caused by taking ticagrelor.The patient's dapt was stopped to avoid expanding the intracranial hemorrhage range.The patient's vital signs are stable and the intracranial hemorrhage is controlled but not resolved.The patient is hospitalized in the intensive care unit for observation.If the patient's condition is stable, the patient is expected to be discharged on (b)(6) 2017.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6567291
MDR Text Key75319590
Report Number2024168-2017-04151
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648212888
UDI-Public(01)08717648212888(17)180103(10)7010461
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 05/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/03/2018
Device Catalogue Number1234350-18
Device Lot Number7010461
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SCAFFOLD: ABSORB GT1 3.0X18
Patient Age58 YR
-
-